INVESTIGADORES
PENNISI Patricia Alejandra
congresos y reuniones científicas
Título:
Endocrine and metabolic effects in Acid-labile subunit deficiency
Autor/es:
DOMENÉ HM; BENGOLEA SV; MARTINEZ A; ROPELATO MG; PENNISI P; SCAGLIA P; HEINRICH JJ; JASPER HG
Lugar:
Punta del Este
Reunión:
Congreso; XV Reunión Anual de la Sociedad Latinoamericana de Endocrinologìa Pediátrica (SLEP); 2002
Institución organizadora:
SLEP
Resumen:
ENDOCRINE AND IVillTABOLIC EFFECTS IN AClD-LAIHLE SUBUNIT DEFICIENCY.
Domené H; Bengolea S; Martínez A; Ropelato M; Scaglia P; Pennisi P; Heinrich JJ; Jasper H.
Division of Endocrinology, Endocrinology Research <;=enter(CEDIE), Children´s Hospi tal and
Division ofPediatrics, JA FemáIldez Hospital, Buenós Aires, Argentina.
IntroductÍGn: Tbe acid-labile subunit (ALS) is an 8S-kDa glycoprotein synthesized in the liver under
the control of GH. ALS stabilizes IGF-I and IGFBP-3 in the circulation by the formation of 150-kDa
temary complexes, reducing the passage of the lGFs to the extravascular compartment, and
extending their half-life. We describe a 17-year old boy with delay of growth and pubertal
development associated with a homozygous inactivating mutation in tbe IGFALS gene.
the control of GH. ALS stabilizes IGF-I and IGFBP-3 in the circulation by the formation of 150-kDa
temary complexes, reducing the passage of the lGFs to the extravascular compartment, and
extending their half-life. We describe a 17-year old boy with delay of growth and pubertal
development associated with a homozygous inactivating mutation in tbe IGFALS gene.
Tbe acid-labile subunit (ALS) is an 8S-kDa glycoprotein synthesized in the liver under
the control of GH. ALS stabilizes IGF-I and IGFBP-3 in the circulation by the formation of 150-kDa
temary complexes, reducing the passage of the lGFs to the extravascular compartment, and
extending their half-life. We describe a 17-year old boy with delay of growth and pubertal
development associated with a homozygous inactivating mutation in tbe IGFALS gene.
Mcthodology and Resulto: At 14.6 years height was 145.2 cm (-2.05 SDS), weight3S.9 kg (-2.34
SDS), Tanner stage 1,botb testes 3 mI. The GH response to provocative test was normal (31.0 ngl
SDS), Tanner stage 1,botb testes 3 mI. The GH response to provocative test was normal (31.0 ngl
At 14.6 years height was 145.2 cm (-2.05 SDS), weight3S.9 kg (-2.34
SDS), Tanner stage 1,botb testes 3 mI. The GH response to provocative test was normal (31.0 nglngl
mI), but spontéU1eousnocturnal secretion was increased (l8.9±12.6 ng/rnl). Both basal IGF-I (31 nglngl
111];
-5.3 SDS) and IGFBP-3 (0.22 /lg/ml; -9.7 SDS) were low, éU1dALS was undetectable. An IGF-I
generation test and a 6-month GH treatment period were ineffective to induce any changes in IGF-I,
IGFBP-3, and ALS levels, as well as to improve growth ve]ocity. Sequencing of the complete coding
region of tbe IGFALS gene revealed a homozygous mutation in exon 2 (1338delG; E35fsXI20). This
frame-shifLing mutation predicts the formation of a truncaled, most likely inactive protein. Circulating
ALS protein was undetectable by westem immunobloting using anLi-ALS antibodies. Incubation of
sel1lm with 1251I_GF-l followed by cross-linking and éUlalyzedby size exclusion column
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
generation test and a 6-month GH treatment period were ineffective to induce any changes in IGF-I,
IGFBP-3, and ALS levels, as well as to improve growth ve]ocity. Sequencing of the complete coding
region of tbe IGFALS gene revealed a homozygous mutation in exon 2 (1338delG; E35fsXI20). This
frame-shifLing mutation predicts the formation of a truncaled, most likely inactive protein. Circulating
ALS protein was undetectable by westem immunobloting using anLi-ALS antibodies. Incubation of
sel1lm with 1251I_GF-l followed by cross-linking and éUlalyzedby size exclusion column
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
/lg/ml; -9.7 SDS) were low, éU1dALS was undetectable. An IGF-I
generation test and a 6-month GH treatment period were ineffective to induce any changes in IGF-I,
IGFBP-3, and ALS levels, as well as to improve growth ve]ocity. Sequencing of the complete coding
region of tbe IGFALS gene revealed a homozygous mutation in exon 2 (1338delG; E35fsXI20). This
frame-shifLing mutation predicts the formation of a truncaled, most likely inactive protein. Circulating
ALS protein was undetectable by westem immunobloting using anLi-ALS antibodies. Incubation of
sel1lm with 1251I_GF-l followed by cross-linking and éUlalyzedby size exclusion column
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
by size exclusion column
chromatography revealed complete inability for temal)´ compJex formation. Oral glucose loads
performed before and during GH treatment showed normal glucose ]evels with exaggerated insulin
responses, indicatjng some degree of insulin resistance. A 3-month period of metformin treatment
reduced basal insulin levels by 47% and insulin sensitivity index improves to 2.1, near to nonnal
value. Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.
Conclusions: The lack of circulating ALS prevents the formation of the ternary complex,
markedly decreases serum IGF-I and IGFBP-3, increases GH secretion, induces insulin resistance,
éU1cp1robably causes pubertal del ay with minimal effect on linear growth. Tbese fjndings suggest that
total circulating IGF-l would not be the major mediator of tbe growth-promoting actions of GH.
Perhaps its main roles are the feedback control on GH secretiol1 éUldthe regulation of carbohydrates
metabolism by facilitatinginsulin action. Further studies may reveal if lGFALS mutations could be
involved in other cases of delay of growth and pubertal development in children.